1364P Treatment and outcome of a real-world cohort of patients with advanced, non-squamous NSCLC and KRAS mutations with a special focus on KRAS G12C
Autor: | Griesinger, F., Eberhardt, W.E.E., Hoffknecht, P., Metzenmacher, M., Wehler, T., Kokowski, K., Alt, J., Schütte, W., Jänicke, M., Fleitz, A., Zacharias, S., Hipper, A., Buller, M., Weichert, W., Groschek, M., Heyde, E. von der, Rauh, J., Dechow, T., Sebastian, M., Thomas, M. |
---|---|
Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S872-S872 |
Databáze: | ScienceDirect |
Externí odkaz: |